Factors associated with death in critically ill patients with coronavirus disease 2019 in the US

…, N ul aain Bhatti, B Mehta, A Williams… - JAMA internal …, 2020 - jamanetwork.com
Importance The US is currently an epicenter of the coronavirus disease 2019 (COVID-19)
pandemic, yet few national data are available on patient characteristics, treatment, and …

Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19

…, N ul aain Bhatti, B Mehta, A Williams… - JAMA internal …, 2021 - jamanetwork.com
Importance Therapies that improve survival in critically ill patients with coronavirus disease
2019 (COVID-19) are needed. Tocilizumab, a monoclonal antibody against the interleukin 6 …

Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States

…, N ul aain Bhatti, B Mehta, A Williams… - American Journal of …, 2021 - Elsevier
Rationale & Objective Underlying kidney disease is an emerging risk factor for more severe
coronavirus disease 2019 (COVID-19) illness. We examined the clinical courses of critically …

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

…, P Apte, R Hicks, CT Cartagena, P Williams… - The Lancet, 2018 - thelancet.com
Background The Zika virus epidemic and associated congenital infections have prompted
rapid vaccine development. We assessed two new DNA vaccines expressing premembrane …

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

…, MB Laurens, CV Plowe, B Flynn, WR Whalen… - Nature medicine, 2016 - nature.com
An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly
protective against controlled human malaria infection (CHMI) 3 weeks after immunization, …

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open …

…, PJ Apte, RT Hicks, CT Cartagena, PV Williams… - The Lancet, 2019 - thelancet.com
Background mAb114 is a single monoclonal antibody that targets the receptor-binding
domain of Ebola virus glycoprotein, which prevents mortality in rhesus macaques treated after …

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation …

…, P Apte, R Hicks, CT Cartagena, P Williams… - The Lancet …, 2021 - thelancet.com
Background Multiple active vaccination approaches have proven ineffective in reducing the
substantial morbidity and mortality caused by respiratory syncytial virus (RSV) in infants and …

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

…, P Apte, CT Cartagena, R Hicks, P Williams… - The Lancet …, 2019 - thelancet.com
Background Human monoclonal antibodies that potently and broadly neutralise HIV-1 are
under development to prevent and treat HIV-1 infection. In this phase 1 clinical trial we aimed …

Comparison of a target trial emulation framework vs Cox regression to estimate the association of corticosteroids with COVID-19 mortality

…, MJ Satlin, W Whalen, D Pan, N Williams… - JAMA Network …, 2022 - jamanetwork.com
Importance Communication and adoption of modern study design and analytical techniques
is of high importance for the improvement of clinical research from observational data. …

A Mutation in the Schizosaccharomyces pombe rae1 Gene Causes Defects in Poly (A)+ RNA Export and in the Cytoskeleton (∗)

JA Brown, A Bharathi, A Ghosh, W Whalen… - Journal of Biological …, 1995 - ASBMB
A collection of fission yeast Schizosaccharomyces pombe conditional mutants was
screened for defective nucleocytoplasmic transport of poly(A) + RNA by fluorescence in situ …